Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juergen Wolf

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cancer Research|July 5, 2005
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factorMartin R Weihrauch, Oliver Manzke, Marc Beyer, et al.
Journal of Palliative Medicine|July 6, 2010
Implementing WHO recommendations for palliative care into routine lung cancer therapy: a feasibility projectJan Gaertner, Juergen Wolf, Dennis Scheicht, et al.
Journal of Thoracic Disease|February 19, 2019
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biologyChristina Alidousty, Till Baar, Carina Heydt, et al.
The American Journal of Surgical Pathology|October 25, 2003
A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocationPatrick Adam, Tiemo Katzenberger, Harald Seeberger, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCTBernhard C Meyer, Bernd B Frericks, Maerthe Voges, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2011
Recommending early integration of palliative care - does it work?Jan Gaertner, Juergen Wolf, Sebastian Frechen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2017
Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancerSusanne Temming, Martin Kocher, Erich Stoelben, et al.
The Journal of Molecular Diagnostics : JMD|August 6, 2019
Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid TumorsCarina Heydt, Vanessa Ruesseler, Roberto Pappesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancerMartin R Weihrauch, Sascha Ansén, Elke Jurkiewicz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancer Research|July 5, 2005
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factorMartin R Weihrauch, Oliver Manzke, Marc Beyer, et al.
Journal of Palliative Medicine|July 6, 2010
Implementing WHO recommendations for palliative care into routine lung cancer therapy: a feasibility projectJan Gaertner, Juergen Wolf, Dennis Scheicht, et al.
Journal of Thoracic Disease|February 19, 2019
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biologyChristina Alidousty, Till Baar, Carina Heydt, et al.
The American Journal of Surgical Pathology|October 25, 2003
A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocationPatrick Adam, Tiemo Katzenberger, Harald Seeberger, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCTBernhard C Meyer, Bernd B Frericks, Maerthe Voges, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2011
Recommending early integration of palliative care - does it work?Jan Gaertner, Juergen Wolf, Sebastian Frechen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2017
Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancerSusanne Temming, Martin Kocher, Erich Stoelben, et al.
The Journal of Molecular Diagnostics : JMD|August 6, 2019
Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid TumorsCarina Heydt, Vanessa Ruesseler, Roberto Pappesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancerMartin R Weihrauch, Sascha Ansén, Elke Jurkiewicz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Pageof 4